J. Sorbel

3.0k total citations
50 papers, 1.1k citations indexed

About

J. Sorbel is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, J. Sorbel has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 41 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in J. Sorbel's work include Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (40 papers) and Liver Disease Diagnosis and Treatment (14 papers). J. Sorbel is often cited by papers focused on Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (40 papers) and Liver Disease Diagnosis and Treatment (14 papers). J. Sorbel collaborates with scholars based in United States, France and Germany. J. Sorbel's co-authors include Franck Rousseau, Patrick Marcellin, Elsa Mondou, Andrea Snow‐Lampart, Katyna Borroto–Esoda, David Frederick, J. C. Christian, Jane Anderson, A. Lynn Snow and Thomas Berg and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

J. Sorbel

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Sorbel United States 16 844 815 185 95 73 50 1.1k
Shou–Dong Lee Taiwan 6 538 0.6× 550 0.7× 30 0.2× 23 0.2× 1 0.0× 6 672
Elmar Jäckel Germany 11 284 0.3× 286 0.4× 53 0.3× 102 1.1× 1 0.0× 20 483
Megan Dring Ireland 8 101 0.1× 123 0.2× 29 0.2× 45 0.5× 9 521
Katsuhiko Fukuda Japan 12 217 0.3× 240 0.3× 50 0.3× 66 0.7× 2 0.0× 23 428
Oriane Fiquet France 9 115 0.1× 80 0.1× 43 0.2× 41 0.4× 12 338
Tuğba Öztürk United States 11 108 0.1× 91 0.1× 188 1.0× 65 0.7× 17 443
Xufei Tan China 10 200 0.2× 84 0.1× 28 0.2× 24 0.3× 1 0.0× 20 374
M. Raptopoulou Greece 11 246 0.3× 219 0.3× 41 0.2× 15 0.2× 22 327
Asuka Nakajima Japan 9 78 0.1× 75 0.1× 23 0.1× 27 0.3× 47 261

Countries citing papers authored by J. Sorbel

Since Specialization
Citations

This map shows the geographic impact of J. Sorbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sorbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sorbel more than expected).

Fields of papers citing papers by J. Sorbel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sorbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sorbel. The network helps show where J. Sorbel may publish in the future.

Co-authorship network of co-authors of J. Sorbel

This figure shows the co-authorship network connecting the top 25 collaborators of J. Sorbel. A scholar is included among the top collaborators of J. Sorbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Sorbel. J. Sorbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonas, Maureen M., Déirdre Kelly, Henry Pollack, et al.. (2012). Efficacy and Safety of Long-term Adefovir Dipivoxil Therapy in Children With Chronic Hepatitis B Infection. The Pediatric Infectious Disease Journal. 31(6). 578–582. 15 indexed citations
2.
Gane, E., E.J. Heathcote, Patrick Marcellin, et al.. (2010). 1006 HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT. Journal of Hepatology. 52. S388–S388. 12 indexed citations
3.
Berg, Thomas, Patrick Marcellin, Fabien Zoulim, et al.. (2010). Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection. Gastroenterology. 139(4). 1207–1217.e3. 115 indexed citations
4.
Manns, M.P., Jenny Heathcote, Patrick Marcellin, et al.. (2010). 1017 EFFICACY OF TENOFOVIR DF TREATMENT IN PATIENTS WITH A SUBOPTIMAL RESPONSE TO ADEFOVIR DIPIVOXIL. Journal of Hepatology. 52. S393–S393. 2 indexed citations
5.
Lavocat, Fabien, Paul Dény, Katyna Borroto–Esoda, et al.. (2009). 934 EVOLUTION OF VIRAL LOAD AND GENOME SEQUENCE IN A CLINICAL TRIAL OF TENOFOVIR/EMTRICITABINE COMBINATION VERSUS TENOFOVIR MONOTHERAPY FOR PATIENTS WITH PREVIOUS ADEFOVIR DIPIVOXIL FAILURE. Journal of Hepatology. 50. S340–S340. 4 indexed citations
6.
Heathcote, E. Jenny, Edward Gane, Robert A. de Man, et al.. (2009). THREE YEARS OF TENOFOVIR DISOPROXIL (TDF) TREATMENT IN HBEAG-POSITIVE PATIENTS (HBEAG plus ) WITH CHRONIC HEPATITIS B (STUDY 103), PRELIMINARY ANALYSIS. Data Archiving and Networked Services (DANS). 50(4). 12 indexed citations
7.
Buti, Marı́a, Stephanos J. Hadziyannis, Philippe Mathurin, et al.. (2008). 75 TENOFOVIR DISOPROXIL FUMARATE (TDF) IS HIGHLY ACTIVE FOR TREATMENT OF CHRONIC HEPATITIS B IN SUBJECTS WITH CIRRHOSIS. Journal of Hepatology. 48. S33–S33. 5 indexed citations
8.
Chittick, Gregory E., et al.. (2008). Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination. International Journal of Clinical Pharmacology and Therapeutics. 46(12). 627–636. 6 indexed citations
9.
Wu, I‐Chin, Mitchell L. Shiffman, Myron J. Tong, et al.. (2008). Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants. Clinical Infectious Diseases. 47(10). 1305–1311. 14 indexed citations
10.
Berg, Thomas, Bjarne Kuno Møller, G Gerken, et al.. (2008). Tenofovir disoproxil fumarate (TDF) versus Emtricitabine plus TDF for treatment of chronic Hepatitis B (CHB) in subjects with persistent viral replication receiving Adefovir dipivoxil (ADV). Zeitschrift für Gastroenterologie. 46(9). 6 indexed citations
11.
Jonas, Maureen M., Déirdre Kelly, Henry Pollack, et al.. (2008). Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology. 47(6). 1863–1871. 66 indexed citations
12.
13.
Wang, Chia, Marı́a Buti, Stephanos J. Hadziyannis, et al.. (2008). M1910 Tenofovir Disoproxil Fumarate (TDF) Is Highly Active for Treatment of Chronic Hepatitis B in Subjects with Cirrhosis. Gastroenterology. 134(4). A–808. 1 indexed citations
14.
Sokal, Étienne, D. Kelly, Henry Pollack, et al.. (2007). Safety, efficacy and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to < 18) with chronic hepatitis B. Journal of Pediatric Gastroenterology and Nutrition. 44. 28–28. 2 indexed citations
15.
Chang, Ting‐Tsung, Myron J. Tong, Piyawat Komolmit, et al.. (2006). Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B. Journal of Hepatology. 44. 7 indexed citations
16.
Gish, Robert G., Huy N. Trinh, Nancy Leung, et al.. (2005). Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study. Journal of Hepatology. 43(1). 60–66. 73 indexed citations
17.
Mondou, Elsa, et al.. (2005). Posttreatment Exacerbation of Hepatitis B Virus (HBV) Infection in Long-Term HBV Trials of Emtricitabine. Clinical Infectious Diseases. 41(5). e45–e47. 20 indexed citations
18.
Marcellin, Patrick, Herve Momméja-Marin, Stephen L. Sacks, et al.. (2004). A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B. Hepatology. 40(1). 140–148. 106 indexed citations
19.
Sorbel, J., Sandra L. Morzorati, Sean O’Connor, T.‐K. Li, & J.C. Christian. (1996). Alcohol Effects on the Heritability of EEG Spectral Power. Alcoholism Clinical and Experimental Research. 20(9). 1523–1527. 24 indexed citations
20.
Slemenda, Charles W., Charles H. Turner, Munro Peacock, et al.. (1996). The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporosis International. 6(2). 178–182. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shou–Dong Lee Breakdown of academic impact, for papers by Elmar Jäckel Breakdown of academic impact, for papers by Megan Dring Breakdown of academic impact, for papers by Katsuhiko Fukuda Breakdown of academic impact, for papers by Oriane Fiquet Breakdown of academic impact, for papers by Tuğba Öztürk Breakdown of academic impact, for papers by Xufei Tan Breakdown of academic impact, for papers by M. Raptopoulou Breakdown of academic impact, for papers by Asuka Nakajima
Rankless by CCL
2026